Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5099217

Cc1ccc(-c2cc(C)ccc2NC(=O)O)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.41
AKR1C2 P52895 1/20 0.41
CHRM3 P20309 4/20 0.40
HDAC7 Q8WUI4 2/20 0.40
NPC1 O15118 3/20 0.39
MAPT P10636 3/20 0.39
ALDH1A1 P00352 2/20 0.39
RAB9A P51151 2/20 0.39
POLB P06746 1/20 0.39
HPGD P15428 2/20 0.39
METAP2 P50579 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
HDAC3 O15379 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC10 Q969S8 1/20 0.37
HDAC11 Q96DB2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5106698 0.93 FABP4 (0.42) CHRM3NPC1MAPTRAB9AMEN1
Trifluoroacetic Acid SCHEMBL5106997 0.90 CHRM3 (0.42) CHRM3NPC1MAPTRAB9AMEN1
Trifluoroacetic Acid SCHEMBL5103243 0.88 AKR1C3 (0.44) AKR1C3AKR1C2HDAC7NPC1MAPT
Trifluoroacetic Acid SCHEMBL5103795 0.87 CHRM3 (0.42) AKR1C3AKR1C2CHRM3HDAC7ALDH1A1
Trifluoroacetic Acid SCHEMBL5103238 0.86 METAP2 (0.38) CHRM3RAB9AMETAP2MEN1KMT2A
Trifluoroacetic Acid SCHEMBL5099116 0.84 CHRM3 (0.47) CHRM3NPC1MAPTRAB9AMEN1
Trifluoroacetic Acid SCHEMBL5113725 0.84 CHRM3 (0.52) CHRM3
Trifluoroacetic Acid SCHEMBL5106872 0.83 MEN1 (0.44) CHRM3MAPTALDH1A1RAB9AMEN1
SCHEMBL5100217 0.82 HDAC7 (0.57) CHRM3HDAC7NPC1MAPTALDH1A1
SCHEMBL5099223 0.81 HPGD (0.43) AKR1C3AKR1C2CHRM3NPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080249127-A1 Muscarinic Acetylcholine Receptor Antagonists LAINE DRAMANE I 2008-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249127-A1 Muscarinic Acetylcholine Receptor Antagonists CHRM3, CHRNG, CHRM2 AKR1C3 1908/4885AKR1C2 2538/4885CHRM3 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.